Latest Advancements in Transcutaneous Electrical Nerve Stimulation (TENS) and Electronic Muscle Stimulation (EMS): Revisiting an Established Therapy with New Possibilities

Abstract

Transcutaneous Electrical Nerve Stimulation (TENS) and Electronic Muscle Stimulation (EMS) are non-invasive therapies widely used for pain relief and neuromuscular adaptation. However, the clinical research supporting the efficacy of TENS in chronic pain management is limited by significant methodological flaws, including small sample sizes and inconsistent reporting of stimulation parameters. TENS modulates pain perception through various techniques, targeting specific nerve fibers and pain pathways. High-frequency TENS is effective for segmental pain control, while low-frequency TENS, reliant on endogenous opioid pathways, may be less effective in opioid-tolerant patients. Additionally, TENS may influence autonomic functions, such as micro-perfusion and sympathetic tone, further broadening its therapeutic potential. EMS, on the other hand, enhances muscle strength and neuromuscular function, particularly in rehabilitation settings, by recruiting additional muscle fibers and improving neuromuscular efficiency. To address the limitations in existing clinical applications, future advancements in TENS and EMS technologies should focus on real-time optimization of stimulation parameters, consistent therapy delivery, and improved accessibility. Integrating automated and personalized adjustments can help streamline treatment, enhance patient compliance, and overcome traditional barriers to the effective implementation of these modalities. Additionally, developing systems that enable remote monitoring and customization of therapy protocols will expand the usability of TENS and EMS in diverse care settings. Future research must focus on rigorous study designs, standardized protocols, and meaningful patient-centered outcomes to fully realize the therapeutic potential of these modalities. Innovations like NXTSTIM EcoAI™ represent a significant advancement in delivering tailored, effective, and patient-friendly pain management and rehabilitation strategies.

Keywords: EMS; TENS; central sensitization; chronic pain; gate control theory; neurotransmitters.

Figure 1

Somatosensory excitatory and inhibitory afferent pathways from the periphery to central circuit: This schematic illustrates the somatosensory excitatory and inhibitory afferent pathways from the periphery to central circuits, emphasizing the role of TENS in modulating pain perception. Nociceptive signals originate from peripheral nociceptors and are transmitted via Aδ and C fibers to the dorsal root ganglion. These signals then travel through the spinothalamic and trigeminothalamic tracts to the thalamus, where they are relayed to the somatosensory cortex for pain perception. Additionally, TENS activates descending inhibitory pathways originating from the brainstem, including serotonergic and noradrenergic tracts, which suppresses nociceptive signaling at the spinal level (Created in BioRender. Green, (M) (2024) https://BioRender.com/o00z001).

Figure 2

Opioid receptor activation interrupts spinothalamic tract pain transmission: The analgesic effects of TENS involve modulation of the activity of descending inhibitory pathways leading to increased release of endogenous opioids, such as endorphins, enkephalins, and dynorphins. These activate opioid receptors, triggering the release of inhibitory neurotransmitters, including glycine, which further attenuate nociceptive signaling the spinal and supraspinal levels (Created in BioRender. Green, (M) (2024) https://BioRender.com/d918047).